Basaglar, a biosimilar insulin glargine product, is available through various manufacturers and pharmacies, with pricing that can fluctuate. For example, in some instances, a 10-milliliter vial of Basaglar KwikPen has been listed for approximately $97.99 at certain online pharmacies [1]. The cost may also depend on insurance coverage and specific pharmacy pricing.
How Does Basaglar Pricing Compare to Lantus?
Basaglar is a follow-on product to Lantus, another brand of insulin glargine. As a biosimilar, Basaglar is designed to be highly similar to Lantus, and it is often marketed at a lower price point. This cost difference is a key factor for patients and healthcare providers when choosing between the two insulins [2].
Where Can I Buy Basaglar Insulin?
Basaglar can be obtained through prescription at most major pharmacies. It is available in different delivery devices, including vials and pre-filled pens like the KwikPen, to suit patient preferences and needs [1].
When Does Patent Protection Expire for Basaglar?
The patent landscape for biosimilars can be complex and is influenced by various factors, including individual patent expiry dates and potential litigation. Information on specific patent expiry timelines for Basaglar is available through resources that track drug patents [3].